Search Login Register

darapladib Summary

Description: a selective lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) inhibitor, on biomarkers of cardiovascular (CV) risk

Key Diseases for which darapladib is Relevant

  1. Atherosclerosis : 1 outcome 10 studies in 16 results
  2. Coronary Disease (Coronary Heart Disease) : 1 outcome 10 studies in 12 results
  3. Acute Coronary Syndrome : 1 outcome 6 studies in 9 results
  4. Atherosclerotic Plaque (Atheroma) : 6 studies in 12 results
  5. Myocardial Infarction : 6 studies in 7 results
Show All >>

Drugs Related to darapladib

  1. 1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)
  2. Methotrexate (Mexate)
  3. canakinumab
  4. Colchicine
  5. varespladib
  6. Secretory Phospholipases A2
  7. Phospholipases (Phospholipase)
  8. Phospholipases A2 (Phospholipase A2)
  9. Amlodipine (Norvasc)
  10. Biological Markers (Surrogate Marker)
Show All >>

Therapies Related to darapladib

  1. Stents

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.